We also did not observe a compensation of c-MYC when targeting HIF-1α through USP25, which has previously been linked to HIF activity28–31 and shown to be upregulated in a PDAC initiation tumor model with HIF1A deletion37. This evidence concerns the gene HIF1A and neoplasm.